Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma
Crossref DOI link: https://doi.org/10.1186/s13046-020-01780-y
Published Online: 2020-12-09
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Teng, Fei
Zhang, Ju-Xiang
Chang, Qi-Meng
Wu, Xu-Bo
Tang, Wei-Guo
Wang, Jian-Fa
Feng, Jin-Feng
Zhang, Zi-Ping
Hu, Zhi-Qiu
Text and Data Mining valid from 2020-12-01
Version of Record valid from 2020-12-09
Article History
First Online: 9 December 2020